Draft Genome Sequence of Acinetobacter bereziniae HPC229, a Carbapenem-Resistant Clinical Strain from Argentina Harboring bla NDM-1 | Zendy

Marco A. Brovedan | Zendy; Patricia Marchiaro | Zendy; Jorgelina Morán-Barrio | Zendy; Santiago Revale | Zendy; Marcela Cameranesi | Zendy; Luciano Brambilla | Zendy; Alejandro M. Viale | Zendy; Adriana S. Limansky | Zendy

Open Access

Draft Genome Sequence of Acinetobacter bereziniae HPC229, a Carbapenem-Resistant Clinical Strain from Argentina Harboring bla _NDM-1

Author(s) -

Marco A. Brovedan,

Patricia Marchiaro,

Jorgelina Morán-Barrio,

Santiago Revale,

Marcela Cameranesi,

Luciano Brambilla,

Alejandro M. Viale,

Adriana S. Limansky

Publication year - 2016

Publication title -

genome announcements

Language(s) - English

Resource type - Journals

ISSN - 2169-8287

DOI - 10.1128/genomea.00117-16

Subject(s) - efflux , whole genome sequencing , biology , strain (injury) , plasmid , multiple drug resistance , acinetobacter , microbiology and biotechnology , genome , adaptation (eye) , sequence (biology) , carbapenem , genetics , gene , drug resistance , antibiotics , anatomy , neuroscience

We report here the draft genome sequence of an NDM-1-producing Acinetobacter bereziniae clinical strain, HPC229. This strain harbors both plasmid and chromosomal resistance determinants toward different β-lactams and aminoglycosides as well as several types of multidrug efflux pumps, most likely representing an adaptation strategy for survival under different environments.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research